E. coli strain found in NYC hospital

Researchers identified a highly resistant strain of Escherichia coli in four patients


Researchers identified a highly resistant strain of Escherichia coli in four patients at a hospital in New York City, according to an article on the Becker's Clinical Leadership & Infection Control.

A study published in Antimicrobial Agents and Chemotherapy said researchers identified the bacteria while monitoring patients with weakened immune systems.

Three of the patients exhibited no symptoms, which increases the risk of unknowingly spreading the bacteria.

While the strain has been described from other parts of the world, it has been very rare in the U.S, according to an author of the study.

Read the article.



April 17, 2019


Topic Area: Infection Control


Recent Posts

EV Charging Stations: Planning for Safety, Convenience, Expansion

Managers need to ensure patient access, coordinate with clinical operations and ensure every phase of construction supports the facility's mission.


Why Ambulatory Surgery Centers Are Turning to Dedicated HVAC Systems

Design experts from Neenan Archistruction explain how single-unit HVAC systems for each operating room enhance infection control, comfort, and resiliency.


Ground Broken on UW Health University Row Medical Center

Construction is expected to be completed by the end of 2027.


Better, More Thorough Cleaning Saves Lives

Cleanliness is the first line of defense to protect patients from killer pathogens, but many hospitals refuse to make it a priority.


Encompass Health Opens the Rehabilitation Hospital of Amarillo

The 50-bed inpatient rehabilitation hospital is now accepting patients.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.